Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qumiao Xu

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|December 13, 2023
Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophilsYanling Liang, Qumiao Xu, Qianqian Gao
Critical Reviews in Immunology|April 6, 2021
CAR-T Cell Therapy: Challenges and OptimizationMei Luo, Hongchang Zhang, Linnan Zhu, et al.
BMC Cancer|January 12, 2024
Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinomaChao Chen, Haozhen Liu, Yanling Li, et al.
Biomed Research International|July 5, 2022
Association of <i>PTPRT</i> Mutations with Cancer Metastasis in Multiple Cancer TypesChao Chen, Haozhen Liu, Qumiao Xu, et al.
Aging|November 17, 2018
Glucose negatively affects Nrf2/SKN-1-mediated innate immunity in <i>C. elegans</i>Le Li, Yi Chen, Changchi Chenzhao, et al.
Journal of Immunological Methods|August 8, 2020
The co-stimulation of anti-CD28 and IL-2 enhances the sensitivity of ELISPOT assays for detection of neoantigen-specific T cells in PBMCYunxia Tang, Linnan Zhu, Qumiao Xu, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Generation of CAR-T Cells for Cancer ImmunotherapyQumiao Xu, Hizkia Harto, Robert Berahovich, et al.
Cancer Medicine|June 15, 2019
Therapeutic potential of CRISPR/Cas9 gene editing in engineered T-cell therapyQianqian Gao, Xuan Dong, Qumiao Xu, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 11, 2015
Site-specific incorporation of probes into RNA polymerase by unnatural-amino-acid mutagenesis and Staudinger-Bertozzi ligationAnirban Chakraborty, Abhishek Mazumder, Miaoxin Lin, et al.
Frontiers in Bioscience (Landmark Edition)|April 15, 2017
FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells <i>in vitro</i> and <i>in vivo</i>Robert Berahovich, Shirley Xu, Hua Zhou, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|December 13, 2023
Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophilsYanling Liang, Qumiao Xu, Qianqian Gao
Critical Reviews in Immunology|April 6, 2021
CAR-T Cell Therapy: Challenges and OptimizationMei Luo, Hongchang Zhang, Linnan Zhu, et al.
BMC Cancer|January 12, 2024
Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinomaChao Chen, Haozhen Liu, Yanling Li, et al.
Biomed Research International|July 5, 2022
Association of <i>PTPRT</i> Mutations with Cancer Metastasis in Multiple Cancer TypesChao Chen, Haozhen Liu, Qumiao Xu, et al.
Aging|November 17, 2018
Glucose negatively affects Nrf2/SKN-1-mediated innate immunity in <i>C. elegans</i>Le Li, Yi Chen, Changchi Chenzhao, et al.
Journal of Immunological Methods|August 8, 2020
The co-stimulation of anti-CD28 and IL-2 enhances the sensitivity of ELISPOT assays for detection of neoantigen-specific T cells in PBMCYunxia Tang, Linnan Zhu, Qumiao Xu, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Generation of CAR-T Cells for Cancer ImmunotherapyQumiao Xu, Hizkia Harto, Robert Berahovich, et al.
Cancer Medicine|June 15, 2019
Therapeutic potential of CRISPR/Cas9 gene editing in engineered T-cell therapyQianqian Gao, Xuan Dong, Qumiao Xu, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 11, 2015
Site-specific incorporation of probes into RNA polymerase by unnatural-amino-acid mutagenesis and Staudinger-Bertozzi ligationAnirban Chakraborty, Abhishek Mazumder, Miaoxin Lin, et al.
Frontiers in Bioscience (Landmark Edition)|April 15, 2017
FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells <i>in vitro</i> and <i>in vivo</i>Robert Berahovich, Shirley Xu, Hua Zhou, et al.
Pageof 3